Please wait while the formulary information is being retrieved.
Drug overview for DAPTOMYCIN (daptomycin):
Generic name: daptomycin (DAP-toe-MYE-sin)
Drug class: Agents to Treat Resistant Gram Positive Organisms
Therapeutic class: Anti-Infective Agents
Daptomycin is a cyclic lipopeptide antibiotic.
Daptomycin is used for the treatment of complicated skin and skin structure infections or bacteremia caused by certain susceptible gram-positive bacteria. The drug should not be used in the treatment of pneumonia.
Generic name: daptomycin (DAP-toe-MYE-sin)
Drug class: Agents to Treat Resistant Gram Positive Organisms
Therapeutic class: Anti-Infective Agents
Daptomycin is a cyclic lipopeptide antibiotic.
Daptomycin is used for the treatment of complicated skin and skin structure infections or bacteremia caused by certain susceptible gram-positive bacteria. The drug should not be used in the treatment of pneumonia.
DRUG IMAGES
DAPTOMYCIN 350 MG VIAL
DAPTOMYCIN 500 MG VIAL
The following indications for DAPTOMYCIN (daptomycin) have been approved by the FDA:
Indications:
Complicated skin and skin structure Enterococcus faecalis infection
Complicated skin and skin structure Staphylococcus aureus infection
Complicated skin and skin structure Streptococcus agalactiae infection
Complicated skin and skin structure Streptococcus dysgalactiae infection
Complicated skin and skin structure Streptococcus pyogenes infection
Right-sided Staphylococcus aureus endocarditis
Staphylococcus aureus septicemia
Professional Synonyms:
Complicated skin and skin soft tissue Enterococcus faecalis infection
Complicated skin and skin soft tissue infection due to Streptococcus pyogenes
Complicated Staphylococcus aureus skin and skin soft tissue infection
Complicated Streptococcus pyogenes skin and skin structure infection
Sepsis due to Staphylococcus aureus
Septicemia due to Staph aureus
Septicemia due to Staphylococcus aureus
Indications:
Complicated skin and skin structure Enterococcus faecalis infection
Complicated skin and skin structure Staphylococcus aureus infection
Complicated skin and skin structure Streptococcus agalactiae infection
Complicated skin and skin structure Streptococcus dysgalactiae infection
Complicated skin and skin structure Streptococcus pyogenes infection
Right-sided Staphylococcus aureus endocarditis
Staphylococcus aureus septicemia
Professional Synonyms:
Complicated skin and skin soft tissue Enterococcus faecalis infection
Complicated skin and skin soft tissue infection due to Streptococcus pyogenes
Complicated Staphylococcus aureus skin and skin soft tissue infection
Complicated Streptococcus pyogenes skin and skin structure infection
Sepsis due to Staphylococcus aureus
Septicemia due to Staph aureus
Septicemia due to Staphylococcus aureus
The following dosing information is available for DAPTOMYCIN (daptomycin):
No enhanced Dosing information available for this drug.
Daptomycin is administered by IV injection (adults only) or IV infusion (adults and pediatric patients 1-17 years of age). Daptomycin is commercially available for IV use as 2 different formulations: a lyophilized powder for solution that does not contain sucrose and a lyophilized powder for solution that contains 713 mg of sucrose per vial. Instructions for storage, reconstitution, and dilution differ for the 2 daptomycin formulations and recommendations for the specific formulation used should be followed.
Additives and other drugs should not be added to daptomycin solutions or infused simultaneously through the same IV line. If the same IV line is used for sequential infusion of different drugs, the line should be flushed with a compatible infusion solution before and after infusion of daptomycin. Daptomycin is not compatible with dextrose-containing diluents (e.g., 5% dextrose injection).
Daptomycin should not be used in conjunction with ReadyMed(R) elastomeric infusion pumps since stability studies identified an impurity (i.e., 2-mercaptobenzothiazole) leaching from this pump system into the daptomycin solution. Strict aseptic technique must be observed in preparing daptomycin solutions since the drug contains no preservative. Daptomycin solutions should be inspected visually for particulate matter prior to administration.
Daptomycin for injection (formulation not containing sucrose): The lyophilized powder should be stored at 2-8degreesC. The reconstituted daptomycin solution (in the original vial) and reconstituted and further diluted solutions (in an IV infusion bag) are stable for 12 hours at room temperature or up to 48 hours when refrigerated at 2-8degreesC; the combined storage time (reconstituted vial and diluted infusion bag) at room temperature or under refrigeration should not exceed 12 or 48 hours, respectively. Daptomycin for injection (formulation containing sucrose): The lyophilized powder should be stored at 20-25degreesC, but may be exposed to 15-30degreesC.
The stability of reconstituted daptomycin solution and reconstituted and further diluted solutions varies based on the specific diluent and container used. (See Table 1.) Table 1: Stability of Daptomycin (formulation containing sucrose) After Reconstitution Container Diluent Stability at Stability at 20-25degreesC 2-8degreesC Vial Sterile water for 1 day 3 days injection Bacteriostatic 2 days 3 days water for injection Syringe Sterile water for 1 day 3 days injection Bacteriostatic 2 days 5 days water for injection Infusion bag Reconstituted 19 hours 3 days with sterile water for injection and immediate dilution in 0.9% sodium chloride injection Reconstituted 2 days 5 days with bacteriostatic water for injection and immediate dilution in 0.9% sodium chloride injection Polypropylene syringe with elastomeric plunger stopper.
Additives and other drugs should not be added to daptomycin solutions or infused simultaneously through the same IV line. If the same IV line is used for sequential infusion of different drugs, the line should be flushed with a compatible infusion solution before and after infusion of daptomycin. Daptomycin is not compatible with dextrose-containing diluents (e.g., 5% dextrose injection).
Daptomycin should not be used in conjunction with ReadyMed(R) elastomeric infusion pumps since stability studies identified an impurity (i.e., 2-mercaptobenzothiazole) leaching from this pump system into the daptomycin solution. Strict aseptic technique must be observed in preparing daptomycin solutions since the drug contains no preservative. Daptomycin solutions should be inspected visually for particulate matter prior to administration.
Daptomycin for injection (formulation not containing sucrose): The lyophilized powder should be stored at 2-8degreesC. The reconstituted daptomycin solution (in the original vial) and reconstituted and further diluted solutions (in an IV infusion bag) are stable for 12 hours at room temperature or up to 48 hours when refrigerated at 2-8degreesC; the combined storage time (reconstituted vial and diluted infusion bag) at room temperature or under refrigeration should not exceed 12 or 48 hours, respectively. Daptomycin for injection (formulation containing sucrose): The lyophilized powder should be stored at 20-25degreesC, but may be exposed to 15-30degreesC.
The stability of reconstituted daptomycin solution and reconstituted and further diluted solutions varies based on the specific diluent and container used. (See Table 1.) Table 1: Stability of Daptomycin (formulation containing sucrose) After Reconstitution Container Diluent Stability at Stability at 20-25degreesC 2-8degreesC Vial Sterile water for 1 day 3 days injection Bacteriostatic 2 days 3 days water for injection Syringe Sterile water for 1 day 3 days injection Bacteriostatic 2 days 5 days water for injection Infusion bag Reconstituted 19 hours 3 days with sterile water for injection and immediate dilution in 0.9% sodium chloride injection Reconstituted 2 days 5 days with bacteriostatic water for injection and immediate dilution in 0.9% sodium chloride injection Polypropylene syringe with elastomeric plunger stopper.
| DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
|---|---|---|
| DAPTOMYCIN 500 MG VIAL | Maintenance | Adults infuse 4 mg/kg over 30 minute(s) by intravenous route once daily |
| DAPTOMYCIN 350 MG VIAL | Maintenance | Adults infuse 4 mg/kg over 30 minute(s) by intravenous route once daily |
| DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
|---|---|---|
| DAPTOMYCIN 500 MG VIAL | Maintenance | Adults infuse 4 mg/kg over 30 minute(s) by intravenous route once daily |
| DAPTOMYCIN 350 MG VIAL | Maintenance | Adults infuse 4 mg/kg over 30 minute(s) by intravenous route once daily |
The following drug interaction information is available for DAPTOMYCIN (daptomycin):
There are 3 contraindications.
These drug combinations generally should not be dispensed or administered to the same patient. A manufacturer label warning that indicates the contraindication warrants inclusion of a drug combination in this category, regardless of clinical evidence or lack of clinical evidence to support the contraindication.
| Drug Interaction | Drug Names |
|---|---|
| Live Typhoid Vaccine/Antimicrobials SEVERITY LEVEL: 1-Contraindicated Drug Combination: This drug combination is contraindicated and generally should not be dispensed or administered to the same patient. MECHANISM OF ACTION: The antimicrobial may be active against the organism in the live-vaccine. Antimicrobial therapy may prevent the vaccine organism from replicating enough to trigger an immune response.(1) CLINICAL EFFECTS: Vaccination may be ineffective. PREDISPOSING FACTORS: None determined. PATIENT MANAGEMENT: Do not give oral typhoid vaccine until 72 hours after the last dose of antimicrobial. If possible, to optimize vaccine effectiveness, do not start antibacterial drugs for 72 hours after the last dose of oral typhoid vaccine. A longer interval should be considered for long-acting antimicrobials, such as azithromycin.(3) DISCUSSION: Because antimicrobial therapy may prevent sufficient vaccine-organism replication to generate an immune response, the manufacturer of live-attenuated typhoid vaccine and the Centers for Disease Control (CDC) state that the vaccine should not be administered to patients receiving antimicrobial therapy.(1-3) |
VIVOTIF |
| Fecal Microbiota Spores/Antibiotics SEVERITY LEVEL: 1-Contraindicated Drug Combination: This drug combination is contraindicated and generally should not be dispensed or administered to the same patient. MECHANISM OF ACTION: Fecal microbiota spores is a suspension of live bacterial spores, which may be compromised by concurrent use of antibiotics.(1) CLINICAL EFFECTS: Antibiotics may decrease the effectiveness of fecal microbiota spores.(1) PREDISPOSING FACTORS: None determined. PATIENT MANAGEMENT: Antibiotics should not be used concurrently with fecal microbiota spores. Antibacterial treatment should be completed for 2 to 4 days before initiating treatment with fecal microbiota spores.(1) DISCUSSION: Antibiotics may compromise the effectiveness of fecal microbiota spores. |
VOWST |
| Fecal Microbiota/Antibiotics SEVERITY LEVEL: 1-Contraindicated Drug Combination: This drug combination is contraindicated and generally should not be dispensed or administered to the same patient. MECHANISM OF ACTION: Fecal microbiota is a suspension of live bacteria, which may be compromised by concurrent use of antibiotics.(1) CLINICAL EFFECTS: Antibiotics may decrease the effectiveness of fecal microbiota.(1) PREDISPOSING FACTORS: None determined. PATIENT MANAGEMENT: Antibiotics should not be used concurrently with fecal microbiota. Antibacterial treatment should be completed for 24 to 72 hours before initiating treatment with fecal microbiota. Do not use antibiotics for up to 8 weeks after fecal microbiota.(1) DISCUSSION: Antibiotics may compromise the effectiveness of fecal microbiota. |
REBYOTA |
There are 1 severe interactions.
These drug interactions can produce serious consequences in most patients. Actions required for severe interactions include, but are not limited to, discontinuing one or both agents, adjusting dosage, altering administration scheduling, and providing additional patient monitoring. Review the full interaction monograph for more information.
| Drug Interaction | Drug Names |
|---|---|
| HMG-CoA Reductase Inhibitors/Daptomycin SEVERITY LEVEL: 2-Severe Interaction: Action is required to reduce the risk of severe adverse interaction. MECHANISM OF ACTION: The exact mechanism is unknown but may involve additive or synergistic effects on skeletal muscle. CLINICAL EFFECTS: Concurrent use of HMG-CoA reductase inhibitors and daptomycin can result in elevated creatinine phosphokinase (CPK) levels and skeletal muscle effects.(1) PREDISPOSING FACTORS: The risk for myopathy or rhabdomyolysis may be greater in patients 65 years and older, inadequately treated hypothyroidism, renal impairment, carnitine deficiency, malignant hyperthermia, or in patients with a history of myopathy or rhabdomyolysis. Patients with a SLCO1B1 polymorphism that leads to decreased function of the hepatic uptake transporter OATP1B1 may have increased statin concentrations and be predisposed to myopathy or rhabdomyolysis. Patients on rosuvastatin with ABCG2 polymorphisms leading to decreased or poor BCRP transporter function may have increased rosuvastatin concentrations and risk of myopathy. Patients on fluvastatin who are CYP2C9 intermediate or poor metabolizers may have increased fluvastatin concentrations and risk of myopathy. PATIENT MANAGEMENT: The manufacturer of daptomycin recommends considering suspending HMG-CoA reductase inhibitor therapy in patients receiving daptomycin. CPK levels should be monitored more frequently than the weekly standard frequency in patients who have recently received HMG-CoA reductase therapy or in whom concurrent therapy is warranted. Closely monitor patients for the development of muscle pain and/or weakness.(1) DISCUSSION: In the Phase 3 Staphylococcus aureus bacteremia/endocarditis trial, 5 of 22 patients who received prior or concurrent HMG Co-A reductase inhibitor therapy developed CPK elevations greater than 500 U/L. At a dose of 6 mg/kg of daptomycin, a total of 11 patients developed CPK elevations greater than 500 U/L. Of these, 4 had prior or concurrent HMG Co-A reductase therapy. Rhabdomyolysis in patients treated concurrently with HMG Co-A reductase inhibitors has been reported in post-marketing experience.(1) In 20 healthy subjects, concurrent simvastatin (40 mg daily) and daptomycin (4 mg/kg daily) was not associated with a higher incidence of adverse effects when compared to 10 subjects receiving placebo.(1) |
AMLODIPINE-ATORVASTATIN, ATORVALIQ, ATORVASTATIN CALCIUM, CADUET, CRESTOR, EZALLOR SPRINKLE, EZETIMIBE-SIMVASTATIN, FLOLIPID, FLUVASTATIN ER, FLUVASTATIN SODIUM, LESCOL XL, LIPITOR, LIVALO, LOVASTATIN, PITAVASTATIN CALCIUM, PRAVASTATIN SODIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN-EZETIMIBE, ROSZET, SIMVASTATIN, VYTORIN, ZOCOR, ZYPITAMAG |
There are 0 moderate interactions.
The following contraindication information is available for DAPTOMYCIN (daptomycin):
Drug contraindication overview.
*Known hypersensitivity to daptomycin.
*Known hypersensitivity to daptomycin.
There are 0 contraindications.
There are 5 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
| Severe List |
|---|
| Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min |
| Chronic kidney disease stage 5 (failure) GFr<15 ml/min |
| Clostridioides difficile infection |
| Eosinophilic pneumonia |
| Myopathy with CK elevation |
There are 1 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| Peripheral neuropathy |
The following adverse reaction information is available for DAPTOMYCIN (daptomycin):
Adverse reaction overview.
Adverse effects occurring in >=2% of adult patients receiving daptomycin for the treatment of complicated skin and skin structure infections in clinical trials include diarrhea, nervous system effects (headache, dizziness), rash, abnormal liver function test results, elevated serum creatine kinase (CK, creatine phosphokinase, CPK) concentrations, urinary tract infections, hypotension, and dyspnea. Adverse effects occurring in >=2% of pediatric patients receiving daptomycin for the treatment of complicated skin and skin structure infections in a clinical trial include diarrhea, vomiting, abdominal pain, pruritus, pyrexia, elevated CK concentrations, and headache. Adverse effects occurring in >=5% of adult patients receiving daptomycin for the treatment of bacteremia/endocarditis in a clinical trial include abdominal pain, insomnia, pharyngolaryngeal pain, infections (sepsis, bacteremia), chest pain, edema, pruritus, increased sweating, elevated CK concentrations, and hypertension. Adverse effects occurring in >=5% of pediatric patients receiving daptomycin for the treatment of bacteremia in a clinical trial include vomiting and elevated CK concentrations.
Adverse effects occurring in >=2% of adult patients receiving daptomycin for the treatment of complicated skin and skin structure infections in clinical trials include diarrhea, nervous system effects (headache, dizziness), rash, abnormal liver function test results, elevated serum creatine kinase (CK, creatine phosphokinase, CPK) concentrations, urinary tract infections, hypotension, and dyspnea. Adverse effects occurring in >=2% of pediatric patients receiving daptomycin for the treatment of complicated skin and skin structure infections in a clinical trial include diarrhea, vomiting, abdominal pain, pruritus, pyrexia, elevated CK concentrations, and headache. Adverse effects occurring in >=5% of adult patients receiving daptomycin for the treatment of bacteremia/endocarditis in a clinical trial include abdominal pain, insomnia, pharyngolaryngeal pain, infections (sepsis, bacteremia), chest pain, edema, pruritus, increased sweating, elevated CK concentrations, and hypertension. Adverse effects occurring in >=5% of pediatric patients receiving daptomycin for the treatment of bacteremia in a clinical trial include vomiting and elevated CK concentrations.
There are 49 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Abnormal hepatic function tests Dyspnea |
Acute cognitive impairment Anemia Candidiasis Chest pain Edema Fungal infection Hypertension Hypotension Increased creatine kinase level Renal failure Skin rash Urinary tract infection |
| Rare/Very Rare |
|---|
|
Acute generalized exanthematous pustulosis Altered mental status Anaphylaxis Angioedema Atrial fibrillation Atrial flutter Bacterial sepsis Blistering skin Bullous dermatitis Clostridioides difficile infection DRESS syndrome Dyskinesia Dysphagia Eosinophilia Eosinophilic pneumonia Erythema Fever Hallucinations Hyperkalemia Hypersensitivity drug reaction Hypomagnesemia Interstitial nephritis Jaundice Leukocytosis Lymphadenopathy Metabolic alkalosis Muscle weakness Myopathy Rhabdomyolysis Stevens-johnson syndrome Supraventricular arrhythmias Thrombocytopenic disorder Thrombocytosis Toxic epidermal necrolysis Vesicular rash |
There are 33 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Diarrhea Headache disorder |
Anorexia Dizziness Hyperhidrosis Insomnia Pruritus of skin |
| Rare/Very Rare |
|---|
|
Abdominal distension Acute abdominal pain Blurred vision Chills Cough Cramps Dysgeusia Eczema Fatigue Flushing General weakness Gingival pain Myalgia Nausea Ocular irritation Paresthesia Peripheral neuropathy Proteinuria Stomatitis Tinnitus Urticaria Vertigo Visual changes Vomiting Vulvovaginal candidiasis Xerostomia |
The following precautions are available for DAPTOMYCIN (daptomycin):
Safety and efficacy of daptomycin have not been established in pediatric patients <1 year of age. Use of daptomycin should be avoided in children younger than 12 months of age because of the potential risk of adverse muscular, neuromuscular, peripheral nervous system, and CNS effects; such adverse effects have been observed in neonatal dogs receiving IV daptomycin. The safety and efficacy of daptomycin for the treatment of complicated skin and skin structure infections and S.
aureus bacteremia have been established in the pediatric patients 1-17 years of age. Use of daptomycin for injection in these age groups is supported by evidence from adequate and well-controlled studies in adults, with additional data from pharmacokinetic studies in pediatric patients, and from safety, efficacy, and pharmacokinetic studies in pediatric patients with complicated skin and skin structure infections and S. aureus bacteremia.
Daptomycin has not been studied in pediatric patients with other bacterial infections. Daptomycin is not indicated in pediatric patients with renal impairment because dosage of the drug has not been established in these patients.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
aureus bacteremia have been established in the pediatric patients 1-17 years of age. Use of daptomycin for injection in these age groups is supported by evidence from adequate and well-controlled studies in adults, with additional data from pharmacokinetic studies in pediatric patients, and from safety, efficacy, and pharmacokinetic studies in pediatric patients with complicated skin and skin structure infections and S. aureus bacteremia.
Daptomycin has not been studied in pediatric patients with other bacterial infections. Daptomycin is not indicated in pediatric patients with renal impairment because dosage of the drug has not been established in these patients.
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
Data on the use of daptomycin in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage. No evidence of adverse developmental outcomes was observed in animal reproduction studies performed in rats and rabbits administered IV daptomycin during organogenesis at doses 2 and 4 times, respectively, the recommended 6-mg/kg human dose (on a body surface area basis).
According to limited published data, daptomycin is distributed into human milk at infant doses of 0.1% of the maternal dose. The effects of daptomycin on the breast-fed infant or on milk production are unknown. Consider the developmental and health benefits of breast-feeding along with the mother's clinical need for daptomycin and any potential adverse effects on the breast-fed infant from the drug or the underlying maternal condition.
Among the total number of adult patients studied in phase 3 clinical trials of daptomycin for the treatment of complicated skin and skin structure infections, 27% were >=65 years of age and 12% were >=75 years of age. In a phase 3 clinical trial of daptomycin for the treatment of bacteremia and endocarditis in adults, 25% of patients were >=65 years of age and 16% were >=75 years of age. There was some evidence from these studies that clinical success rates were lower and treatment-emergent adverse effects were more common in geriatric patients >=65 years of age compared with younger adults.
Although daptomycin exposures are higher in healthy geriatric adults than in healthy young adults, adjustment of daptomycin dosage is not necessary in geriatric patients based solely on age. However, age-related decreases in renal function should be considered when selecting dosage in geriatric patients.
Although daptomycin exposures are higher in healthy geriatric adults than in healthy young adults, adjustment of daptomycin dosage is not necessary in geriatric patients based solely on age. However, age-related decreases in renal function should be considered when selecting dosage in geriatric patients.
The following prioritized warning is available for DAPTOMYCIN (daptomycin):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for DAPTOMYCIN (daptomycin)'s list of indications:
| Complicated skin and skin structure s. aureus infection | |
| B95.6 | Staphylococcus aureus as the cause of diseases classified elsewhere |
| B95.61 | Methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere |
| B95.62 | Methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere |
| H00.03 | Abscess of eyelid |
| H00.031 | Abscess of right upper eyelid |
| H00.032 | Abscess of right lower eyelid |
| H00.033 | Abscess of eyelid right eye, unspecified eyelid |
| H00.034 | Abscess of left upper eyelid |
| H00.035 | Abscess of left lower eyelid |
| H00.036 | Abscess of eyelid left eye, unspecified eyelid |
| H00.039 | Abscess of eyelid unspecified eye, unspecified eyelid |
| H60.0 | Abscess of external ear |
| H60.00 | Abscess of external ear, unspecified ear |
| H60.01 | Abscess of right external ear |
| H60.02 | Abscess of left external ear |
| H60.03 | Abscess of external ear, bilateral |
| H60.1 | Cellulitis of external ear |
| H60.10 | Cellulitis of external ear, unspecified ear |
| H60.11 | Cellulitis of right external ear |
| H60.12 | Cellulitis of left external ear |
| H60.13 | Cellulitis of external ear, bilateral |
| J34.0 | Abscess, furuncle and carbuncle of nose |
| K61 | Abscess of anal and rectal regions |
| K61.0 | Anal abscess |
| K61.1 | Rectal abscess |
| K61.2 | Anorectal abscess |
| K61.3 | Ischiorectal abscess |
| K61.4 | Intrasphincteric abscess |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L02.0 | Cutaneous abscess, furuncle and carbuncle of face |
| L02.01 | Cutaneous abscess of face |
| L02.03 | Carbuncle of face |
| L02.1 | Cutaneous abscess, furuncle and carbuncle of neck |
| L02.11 | Cutaneous abscess of neck |
| L02.13 | Carbuncle of neck |
| L02.2 | Cutaneous abscess, furuncle and carbuncle of trunk |
| L02.21 | Cutaneous abscess of trunk |
| L02.211 | Cutaneous abscess of abdominal wall |
| L02.212 | Cutaneous abscess of back [any part, except buttock and flank] |
| L02.213 | Cutaneous abscess of chest wall |
| L02.214 | Cutaneous abscess of groin |
| L02.215 | Cutaneous abscess of perineum |
| L02.216 | Cutaneous abscess of umbilicus |
| L02.217 | Cutaneous abscess of flank |
| L02.219 | Cutaneous abscess of trunk, unspecified |
| L02.23 | Carbuncle of trunk |
| L02.231 | Carbuncle of abdominal wall |
| L02.232 | Carbuncle of back [any part, except buttock and flank] |
| L02.233 | Carbuncle of chest wall |
| L02.234 | Carbuncle of groin |
| L02.235 | Carbuncle of perineum |
| L02.236 | Carbuncle of umbilicus |
| L02.237 | Carbuncle of flank |
| L02.239 | Carbuncle of trunk, unspecified |
| L02.3 | Cutaneous abscess, furuncle and carbuncle of buttock |
| L02.31 | Cutaneous abscess of buttock |
| L02.33 | Carbuncle of buttock |
| L02.4 | Cutaneous abscess, furuncle and carbuncle of limb |
| L02.41 | Cutaneous abscess of limb |
| L02.411 | Cutaneous abscess of right axilla |
| L02.412 | Cutaneous abscess of left axilla |
| L02.413 | Cutaneous abscess of right upper limb |
| L02.414 | Cutaneous abscess of left upper limb |
| L02.415 | Cutaneous abscess of right lower limb |
| L02.416 | Cutaneous abscess of left lower limb |
| L02.419 | Cutaneous abscess of limb, unspecified |
| L02.43 | Carbuncle of limb |
| L02.431 | Carbuncle of right axilla |
| L02.432 | Carbuncle of left axilla |
| L02.433 | Carbuncle of right upper limb |
| L02.434 | Carbuncle of left upper limb |
| L02.435 | Carbuncle of right lower limb |
| L02.436 | Carbuncle of left lower limb |
| L02.439 | Carbuncle of limb, unspecified |
| L02.5 | Cutaneous abscess, furuncle and carbuncle of hand |
| L02.51 | Cutaneous abscess of hand |
| L02.511 | Cutaneous abscess of right hand |
| L02.512 | Cutaneous abscess of left hand |
| L02.519 | Cutaneous abscess of unspecified hand |
| L02.53 | Carbuncle of hand |
| L02.531 | Carbuncle of right hand |
| L02.532 | Carbuncle of left hand |
| L02.539 | Carbuncle of unspecified hand |
| L02.6 | Cutaneous abscess, furuncle and carbuncle of foot |
| L02.61 | Cutaneous abscess of foot |
| L02.611 | Cutaneous abscess of right foot |
| L02.612 | Cutaneous abscess of left foot |
| L02.619 | Cutaneous abscess of unspecified foot |
| L02.63 | Carbuncle of foot |
| L02.631 | Carbuncle of right foot |
| L02.632 | Carbuncle of left foot |
| L02.639 | Carbuncle of unspecified foot |
| L02.8 | Cutaneous abscess, furuncle and carbuncle of other sites |
| L02.81 | Cutaneous abscess of other sites |
| L02.811 | Cutaneous abscess of head [any part, except face] |
| L02.818 | Cutaneous abscess of other sites |
| L02.83 | Carbuncle of other sites |
| L02.831 | Carbuncle of head [any part, except face] |
| L02.838 | Carbuncle of other sites |
| L02.9 | Cutaneous abscess, furuncle and carbuncle, unspecified |
| L02.91 | Cutaneous abscess, unspecified |
| L02.93 | Carbuncle, unspecified |
| L03 | Cellulitis and acute lymphangitis |
| L03.0 | Cellulitis and acute lymphangitis of finger and toe |
| L03.01 | Cellulitis of finger |
| L03.011 | Cellulitis of right finger |
| L03.012 | Cellulitis of left finger |
| L03.019 | Cellulitis of unspecified finger |
| L03.02 | Acute lymphangitis of finger |
| L03.021 | Acute lymphangitis of right finger |
| L03.022 | Acute lymphangitis of left finger |
| L03.029 | Acute lymphangitis of unspecified finger |
| L03.03 | Cellulitis of toe |
| L03.031 | Cellulitis of right toe |
| L03.032 | Cellulitis of left toe |
| L03.039 | Cellulitis of unspecified toe |
| L03.04 | Acute lymphangitis of toe |
| L03.041 | Acute lymphangitis of right toe |
| L03.042 | Acute lymphangitis of left toe |
| L03.049 | Acute lymphangitis of unspecified toe |
| L03.1 | Cellulitis and acute lymphangitis of other parts of limb |
| L03.11 | Cellulitis of other parts of limb |
| L03.111 | Cellulitis of right axilla |
| L03.112 | Cellulitis of left axilla |
| L03.113 | Cellulitis of right upper limb |
| L03.114 | Cellulitis of left upper limb |
| L03.115 | Cellulitis of right lower limb |
| L03.116 | Cellulitis of left lower limb |
| L03.119 | Cellulitis of unspecified part of limb |
| L03.12 | Acute lymphangitis of other parts of limb |
| L03.121 | Acute lymphangitis of right axilla |
| L03.122 | Acute lymphangitis of left axilla |
| L03.123 | Acute lymphangitis of right upper limb |
| L03.124 | Acute lymphangitis of left upper limb |
| L03.125 | Acute lymphangitis of right lower limb |
| L03.126 | Acute lymphangitis of left lower limb |
| L03.129 | Acute lymphangitis of unspecified part of limb |
| L03.2 | Cellulitis and acute lymphangitis of face and neck |
| L03.21 | Cellulitis and acute lymphangitis of face |
| L03.211 | Cellulitis of face |
| L03.212 | Acute lymphangitis of face |
| L03.22 | Cellulitis and acute lymphangitis of neck |
| L03.221 | Cellulitis of neck |
| L03.222 | Acute lymphangitis of neck |
| L03.3 | Cellulitis and acute lymphangitis of trunk |
| L03.31 | Cellulitis of trunk |
| L03.311 | Cellulitis of abdominal wall |
| L03.312 | Cellulitis of back [any part except buttock and flank] |
| L03.313 | Cellulitis of chest wall |
| L03.314 | Cellulitis of groin |
| L03.315 | Cellulitis of perineum |
| L03.316 | Cellulitis of umbilicus |
| L03.317 | Cellulitis of buttock |
| L03.319 | Cellulitis of trunk, unspecified |
| L03.31A | Cellulitis of flank |
| L03.32 | Acute lymphangitis of trunk |
| L03.321 | Acute lymphangitis of abdominal wall |
| L03.322 | Acute lymphangitis of back [any part except buttock and flank] |
| L03.323 | Acute lymphangitis of chest wall |
| L03.324 | Acute lymphangitis of groin |
| L03.325 | Acute lymphangitis of perineum |
| L03.326 | Acute lymphangitis of umbilicus |
| L03.327 | Acute lymphangitis of buttock |
| L03.329 | Acute lymphangitis of trunk, unspecified |
| L03.32A | Acute lymphangitis of flank |
| L03.8 | Cellulitis and acute lymphangitis of other sites |
| L03.81 | Cellulitis of other sites |
| L03.811 | Cellulitis of head [any part, except face] |
| L03.818 | Cellulitis of other sites |
| L03.89 | Acute lymphangitis of other sites |
| L03.891 | Acute lymphangitis of head [any part, except face] |
| L03.898 | Acute lymphangitis of other sites |
| L03.9 | Cellulitis and acute lymphangitis, unspecified |
| L03.90 | Cellulitis, unspecified |
| L03.91 | Acute lymphangitis, unspecified |
| L05.0 | Pilonidal cyst and sinus with abscess |
| L05.01 | Pilonidal cyst with abscess |
| L05.02 | Pilonidal sinus with abscess |
| L08.0 | Pyoderma |
| M72.6 | Necrotizing fasciitis |
| N48.22 | Cellulitis of corpus cavernosum and penis |
| N75.1 | Abscess of bartholin's gland |
| N76.4 | Abscess of vulva |
| O91 | Infections of breast associated with pregnancy, the puerperium and lactation |
| O91.0 | Infection of nipple associated with pregnancy, the puerperium and lactation |
| O91.01 | Infection of nipple associated with pregnancy |
| O91.011 | Infection of nipple associated with pregnancy, first trimester |
| O91.012 | Infection of nipple associated with pregnancy, second trimester |
| O91.013 | Infection of nipple associated with pregnancy, third trimester |
| O91.019 | Infection of nipple associated with pregnancy, unspecified trimester |
| O91.02 | Infection of nipple associated with the puerperium |
| O91.03 | Infection of nipple associated with lactation |
| O91.1 | Abscess of breast associated with pregnancy, the puerperium and lactation |
| O91.11 | Abscess of breast associated with pregnancy |
| O91.111 | Abscess of breast associated with pregnancy, first trimester |
| O91.112 | Abscess of breast associated with pregnancy, second trimester |
| O91.113 | Abscess of breast associated with pregnancy, third trimester |
| O91.119 | Abscess of breast associated with pregnancy, unspecified trimester |
| O91.12 | Abscess of breast associated with the puerperium |
| O91.13 | Abscess of breast associated with lactation |
| Complicated skin structure e. faecalis infection | |
| B95.2 | Enterococcus as the cause of diseases classified elsewhere |
| H00.03 | Abscess of eyelid |
| H00.031 | Abscess of right upper eyelid |
| H00.032 | Abscess of right lower eyelid |
| H00.033 | Abscess of eyelid right eye, unspecified eyelid |
| H00.034 | Abscess of left upper eyelid |
| H00.035 | Abscess of left lower eyelid |
| H00.036 | Abscess of eyelid left eye, unspecified eyelid |
| H00.039 | Abscess of eyelid unspecified eye, unspecified eyelid |
| H60.0 | Abscess of external ear |
| H60.00 | Abscess of external ear, unspecified ear |
| H60.01 | Abscess of right external ear |
| H60.02 | Abscess of left external ear |
| H60.03 | Abscess of external ear, bilateral |
| H60.1 | Cellulitis of external ear |
| H60.10 | Cellulitis of external ear, unspecified ear |
| H60.11 | Cellulitis of right external ear |
| H60.12 | Cellulitis of left external ear |
| H60.13 | Cellulitis of external ear, bilateral |
| J34.0 | Abscess, furuncle and carbuncle of nose |
| K61 | Abscess of anal and rectal regions |
| K61.0 | Anal abscess |
| K61.1 | Rectal abscess |
| K61.2 | Anorectal abscess |
| K61.3 | Ischiorectal abscess |
| K61.4 | Intrasphincteric abscess |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L02.0 | Cutaneous abscess, furuncle and carbuncle of face |
| L02.01 | Cutaneous abscess of face |
| L02.03 | Carbuncle of face |
| L02.1 | Cutaneous abscess, furuncle and carbuncle of neck |
| L02.11 | Cutaneous abscess of neck |
| L02.13 | Carbuncle of neck |
| L02.2 | Cutaneous abscess, furuncle and carbuncle of trunk |
| L02.21 | Cutaneous abscess of trunk |
| L02.211 | Cutaneous abscess of abdominal wall |
| L02.212 | Cutaneous abscess of back [any part, except buttock and flank] |
| L02.213 | Cutaneous abscess of chest wall |
| L02.214 | Cutaneous abscess of groin |
| L02.215 | Cutaneous abscess of perineum |
| L02.216 | Cutaneous abscess of umbilicus |
| L02.217 | Cutaneous abscess of flank |
| L02.219 | Cutaneous abscess of trunk, unspecified |
| L02.23 | Carbuncle of trunk |
| L02.231 | Carbuncle of abdominal wall |
| L02.232 | Carbuncle of back [any part, except buttock and flank] |
| L02.233 | Carbuncle of chest wall |
| L02.234 | Carbuncle of groin |
| L02.235 | Carbuncle of perineum |
| L02.236 | Carbuncle of umbilicus |
| L02.237 | Carbuncle of flank |
| L02.239 | Carbuncle of trunk, unspecified |
| L02.3 | Cutaneous abscess, furuncle and carbuncle of buttock |
| L02.31 | Cutaneous abscess of buttock |
| L02.33 | Carbuncle of buttock |
| L02.4 | Cutaneous abscess, furuncle and carbuncle of limb |
| L02.41 | Cutaneous abscess of limb |
| L02.411 | Cutaneous abscess of right axilla |
| L02.412 | Cutaneous abscess of left axilla |
| L02.413 | Cutaneous abscess of right upper limb |
| L02.414 | Cutaneous abscess of left upper limb |
| L02.415 | Cutaneous abscess of right lower limb |
| L02.416 | Cutaneous abscess of left lower limb |
| L02.419 | Cutaneous abscess of limb, unspecified |
| L02.43 | Carbuncle of limb |
| L02.431 | Carbuncle of right axilla |
| L02.432 | Carbuncle of left axilla |
| L02.433 | Carbuncle of right upper limb |
| L02.434 | Carbuncle of left upper limb |
| L02.435 | Carbuncle of right lower limb |
| L02.436 | Carbuncle of left lower limb |
| L02.439 | Carbuncle of limb, unspecified |
| L02.5 | Cutaneous abscess, furuncle and carbuncle of hand |
| L02.51 | Cutaneous abscess of hand |
| L02.511 | Cutaneous abscess of right hand |
| L02.512 | Cutaneous abscess of left hand |
| L02.519 | Cutaneous abscess of unspecified hand |
| L02.53 | Carbuncle of hand |
| L02.531 | Carbuncle of right hand |
| L02.532 | Carbuncle of left hand |
| L02.539 | Carbuncle of unspecified hand |
| L02.6 | Cutaneous abscess, furuncle and carbuncle of foot |
| L02.61 | Cutaneous abscess of foot |
| L02.611 | Cutaneous abscess of right foot |
| L02.612 | Cutaneous abscess of left foot |
| L02.619 | Cutaneous abscess of unspecified foot |
| L02.63 | Carbuncle of foot |
| L02.631 | Carbuncle of right foot |
| L02.632 | Carbuncle of left foot |
| L02.639 | Carbuncle of unspecified foot |
| L02.8 | Cutaneous abscess, furuncle and carbuncle of other sites |
| L02.81 | Cutaneous abscess of other sites |
| L02.811 | Cutaneous abscess of head [any part, except face] |
| L02.818 | Cutaneous abscess of other sites |
| L02.83 | Carbuncle of other sites |
| L02.831 | Carbuncle of head [any part, except face] |
| L02.838 | Carbuncle of other sites |
| L02.9 | Cutaneous abscess, furuncle and carbuncle, unspecified |
| L02.91 | Cutaneous abscess, unspecified |
| L02.93 | Carbuncle, unspecified |
| L03 | Cellulitis and acute lymphangitis |
| L03.0 | Cellulitis and acute lymphangitis of finger and toe |
| L03.01 | Cellulitis of finger |
| L03.011 | Cellulitis of right finger |
| L03.012 | Cellulitis of left finger |
| L03.019 | Cellulitis of unspecified finger |
| L03.02 | Acute lymphangitis of finger |
| L03.021 | Acute lymphangitis of right finger |
| L03.022 | Acute lymphangitis of left finger |
| L03.029 | Acute lymphangitis of unspecified finger |
| L03.03 | Cellulitis of toe |
| L03.031 | Cellulitis of right toe |
| L03.032 | Cellulitis of left toe |
| L03.039 | Cellulitis of unspecified toe |
| L03.04 | Acute lymphangitis of toe |
| L03.041 | Acute lymphangitis of right toe |
| L03.042 | Acute lymphangitis of left toe |
| L03.049 | Acute lymphangitis of unspecified toe |
| L03.1 | Cellulitis and acute lymphangitis of other parts of limb |
| L03.11 | Cellulitis of other parts of limb |
| L03.111 | Cellulitis of right axilla |
| L03.112 | Cellulitis of left axilla |
| L03.113 | Cellulitis of right upper limb |
| L03.114 | Cellulitis of left upper limb |
| L03.115 | Cellulitis of right lower limb |
| L03.116 | Cellulitis of left lower limb |
| L03.119 | Cellulitis of unspecified part of limb |
| L03.12 | Acute lymphangitis of other parts of limb |
| L03.121 | Acute lymphangitis of right axilla |
| L03.122 | Acute lymphangitis of left axilla |
| L03.123 | Acute lymphangitis of right upper limb |
| L03.124 | Acute lymphangitis of left upper limb |
| L03.125 | Acute lymphangitis of right lower limb |
| L03.126 | Acute lymphangitis of left lower limb |
| L03.129 | Acute lymphangitis of unspecified part of limb |
| L03.2 | Cellulitis and acute lymphangitis of face and neck |
| L03.21 | Cellulitis and acute lymphangitis of face |
| L03.211 | Cellulitis of face |
| L03.212 | Acute lymphangitis of face |
| L03.22 | Cellulitis and acute lymphangitis of neck |
| L03.221 | Cellulitis of neck |
| L03.222 | Acute lymphangitis of neck |
| L03.3 | Cellulitis and acute lymphangitis of trunk |
| L03.31 | Cellulitis of trunk |
| L03.311 | Cellulitis of abdominal wall |
| L03.312 | Cellulitis of back [any part except buttock and flank] |
| L03.313 | Cellulitis of chest wall |
| L03.314 | Cellulitis of groin |
| L03.315 | Cellulitis of perineum |
| L03.316 | Cellulitis of umbilicus |
| L03.317 | Cellulitis of buttock |
| L03.319 | Cellulitis of trunk, unspecified |
| L03.31A | Cellulitis of flank |
| L03.32 | Acute lymphangitis of trunk |
| L03.321 | Acute lymphangitis of abdominal wall |
| L03.322 | Acute lymphangitis of back [any part except buttock and flank] |
| L03.323 | Acute lymphangitis of chest wall |
| L03.324 | Acute lymphangitis of groin |
| L03.325 | Acute lymphangitis of perineum |
| L03.326 | Acute lymphangitis of umbilicus |
| L03.327 | Acute lymphangitis of buttock |
| L03.329 | Acute lymphangitis of trunk, unspecified |
| L03.32A | Acute lymphangitis of flank |
| L03.8 | Cellulitis and acute lymphangitis of other sites |
| L03.81 | Cellulitis of other sites |
| L03.811 | Cellulitis of head [any part, except face] |
| L03.818 | Cellulitis of other sites |
| L03.89 | Acute lymphangitis of other sites |
| L03.891 | Acute lymphangitis of head [any part, except face] |
| L03.898 | Acute lymphangitis of other sites |
| L03.9 | Cellulitis and acute lymphangitis, unspecified |
| L03.90 | Cellulitis, unspecified |
| L03.91 | Acute lymphangitis, unspecified |
| L05.0 | Pilonidal cyst and sinus with abscess |
| L05.01 | Pilonidal cyst with abscess |
| L05.02 | Pilonidal sinus with abscess |
| L08.0 | Pyoderma |
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| L08.9 | Local infection of the skin and subcutaneous tissue, unspecified |
| N48.21 | Abscess of corpus cavernosum and penis |
| N48.22 | Cellulitis of corpus cavernosum and penis |
| N75.1 | Abscess of bartholin's gland |
| N76.4 | Abscess of vulva |
| O91 | Infections of breast associated with pregnancy, the puerperium and lactation |
| O91.0 | Infection of nipple associated with pregnancy, the puerperium and lactation |
| O91.01 | Infection of nipple associated with pregnancy |
| O91.011 | Infection of nipple associated with pregnancy, first trimester |
| O91.012 | Infection of nipple associated with pregnancy, second trimester |
| O91.013 | Infection of nipple associated with pregnancy, third trimester |
| O91.019 | Infection of nipple associated with pregnancy, unspecified trimester |
| O91.02 | Infection of nipple associated with the puerperium |
| O91.03 | Infection of nipple associated with lactation |
| O91.1 | Abscess of breast associated with pregnancy, the puerperium and lactation |
| O91.11 | Abscess of breast associated with pregnancy |
| O91.111 | Abscess of breast associated with pregnancy, first trimester |
| O91.112 | Abscess of breast associated with pregnancy, second trimester |
| O91.113 | Abscess of breast associated with pregnancy, third trimester |
| O91.119 | Abscess of breast associated with pregnancy, unspecified trimester |
| O91.12 | Abscess of breast associated with the puerperium |
| O91.13 | Abscess of breast associated with lactation |
| Complicated skin structure s. agalactiae infection | |
| B95.1 | Streptococcus, group b, as the cause of diseases classified elsewhere |
| H00.03 | Abscess of eyelid |
| H00.031 | Abscess of right upper eyelid |
| H00.032 | Abscess of right lower eyelid |
| H00.033 | Abscess of eyelid right eye, unspecified eyelid |
| H00.034 | Abscess of left upper eyelid |
| H00.035 | Abscess of left lower eyelid |
| H00.036 | Abscess of eyelid left eye, unspecified eyelid |
| H00.039 | Abscess of eyelid unspecified eye, unspecified eyelid |
| H60.0 | Abscess of external ear |
| H60.00 | Abscess of external ear, unspecified ear |
| H60.01 | Abscess of right external ear |
| H60.02 | Abscess of left external ear |
| H60.03 | Abscess of external ear, bilateral |
| H60.1 | Cellulitis of external ear |
| H60.10 | Cellulitis of external ear, unspecified ear |
| H60.11 | Cellulitis of right external ear |
| H60.12 | Cellulitis of left external ear |
| H60.13 | Cellulitis of external ear, bilateral |
| J34.0 | Abscess, furuncle and carbuncle of nose |
| K61 | Abscess of anal and rectal regions |
| K61.0 | Anal abscess |
| K61.1 | Rectal abscess |
| K61.2 | Anorectal abscess |
| K61.3 | Ischiorectal abscess |
| K61.4 | Intrasphincteric abscess |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L02.0 | Cutaneous abscess, furuncle and carbuncle of face |
| L02.01 | Cutaneous abscess of face |
| L02.03 | Carbuncle of face |
| L02.1 | Cutaneous abscess, furuncle and carbuncle of neck |
| L02.11 | Cutaneous abscess of neck |
| L02.13 | Carbuncle of neck |
| L02.2 | Cutaneous abscess, furuncle and carbuncle of trunk |
| L02.21 | Cutaneous abscess of trunk |
| L02.211 | Cutaneous abscess of abdominal wall |
| L02.212 | Cutaneous abscess of back [any part, except buttock and flank] |
| L02.213 | Cutaneous abscess of chest wall |
| L02.214 | Cutaneous abscess of groin |
| L02.215 | Cutaneous abscess of perineum |
| L02.216 | Cutaneous abscess of umbilicus |
| L02.217 | Cutaneous abscess of flank |
| L02.219 | Cutaneous abscess of trunk, unspecified |
| L02.23 | Carbuncle of trunk |
| L02.231 | Carbuncle of abdominal wall |
| L02.232 | Carbuncle of back [any part, except buttock and flank] |
| L02.233 | Carbuncle of chest wall |
| L02.234 | Carbuncle of groin |
| L02.235 | Carbuncle of perineum |
| L02.236 | Carbuncle of umbilicus |
| L02.237 | Carbuncle of flank |
| L02.239 | Carbuncle of trunk, unspecified |
| L02.3 | Cutaneous abscess, furuncle and carbuncle of buttock |
| L02.31 | Cutaneous abscess of buttock |
| L02.33 | Carbuncle of buttock |
| L02.4 | Cutaneous abscess, furuncle and carbuncle of limb |
| L02.41 | Cutaneous abscess of limb |
| L02.411 | Cutaneous abscess of right axilla |
| L02.412 | Cutaneous abscess of left axilla |
| L02.413 | Cutaneous abscess of right upper limb |
| L02.414 | Cutaneous abscess of left upper limb |
| L02.415 | Cutaneous abscess of right lower limb |
| L02.416 | Cutaneous abscess of left lower limb |
| L02.419 | Cutaneous abscess of limb, unspecified |
| L02.43 | Carbuncle of limb |
| L02.431 | Carbuncle of right axilla |
| L02.432 | Carbuncle of left axilla |
| L02.433 | Carbuncle of right upper limb |
| L02.434 | Carbuncle of left upper limb |
| L02.435 | Carbuncle of right lower limb |
| L02.436 | Carbuncle of left lower limb |
| L02.439 | Carbuncle of limb, unspecified |
| L02.5 | Cutaneous abscess, furuncle and carbuncle of hand |
| L02.51 | Cutaneous abscess of hand |
| L02.511 | Cutaneous abscess of right hand |
| L02.512 | Cutaneous abscess of left hand |
| L02.519 | Cutaneous abscess of unspecified hand |
| L02.53 | Carbuncle of hand |
| L02.531 | Carbuncle of right hand |
| L02.532 | Carbuncle of left hand |
| L02.539 | Carbuncle of unspecified hand |
| L02.6 | Cutaneous abscess, furuncle and carbuncle of foot |
| L02.61 | Cutaneous abscess of foot |
| L02.611 | Cutaneous abscess of right foot |
| L02.612 | Cutaneous abscess of left foot |
| L02.619 | Cutaneous abscess of unspecified foot |
| L02.63 | Carbuncle of foot |
| L02.631 | Carbuncle of right foot |
| L02.632 | Carbuncle of left foot |
| L02.639 | Carbuncle of unspecified foot |
| L02.8 | Cutaneous abscess, furuncle and carbuncle of other sites |
| L02.81 | Cutaneous abscess of other sites |
| L02.811 | Cutaneous abscess of head [any part, except face] |
| L02.818 | Cutaneous abscess of other sites |
| L02.83 | Carbuncle of other sites |
| L02.831 | Carbuncle of head [any part, except face] |
| L02.838 | Carbuncle of other sites |
| L02.9 | Cutaneous abscess, furuncle and carbuncle, unspecified |
| L02.91 | Cutaneous abscess, unspecified |
| L02.93 | Carbuncle, unspecified |
| L03 | Cellulitis and acute lymphangitis |
| L03.0 | Cellulitis and acute lymphangitis of finger and toe |
| L03.01 | Cellulitis of finger |
| L03.011 | Cellulitis of right finger |
| L03.012 | Cellulitis of left finger |
| L03.019 | Cellulitis of unspecified finger |
| L03.02 | Acute lymphangitis of finger |
| L03.021 | Acute lymphangitis of right finger |
| L03.022 | Acute lymphangitis of left finger |
| L03.029 | Acute lymphangitis of unspecified finger |
| L03.03 | Cellulitis of toe |
| L03.031 | Cellulitis of right toe |
| L03.032 | Cellulitis of left toe |
| L03.039 | Cellulitis of unspecified toe |
| L03.04 | Acute lymphangitis of toe |
| L03.041 | Acute lymphangitis of right toe |
| L03.042 | Acute lymphangitis of left toe |
| L03.049 | Acute lymphangitis of unspecified toe |
| L03.1 | Cellulitis and acute lymphangitis of other parts of limb |
| L03.11 | Cellulitis of other parts of limb |
| L03.111 | Cellulitis of right axilla |
| L03.112 | Cellulitis of left axilla |
| L03.113 | Cellulitis of right upper limb |
| L03.114 | Cellulitis of left upper limb |
| L03.115 | Cellulitis of right lower limb |
| L03.116 | Cellulitis of left lower limb |
| L03.119 | Cellulitis of unspecified part of limb |
| L03.12 | Acute lymphangitis of other parts of limb |
| L03.121 | Acute lymphangitis of right axilla |
| L03.122 | Acute lymphangitis of left axilla |
| L03.123 | Acute lymphangitis of right upper limb |
| L03.124 | Acute lymphangitis of left upper limb |
| L03.125 | Acute lymphangitis of right lower limb |
| L03.126 | Acute lymphangitis of left lower limb |
| L03.129 | Acute lymphangitis of unspecified part of limb |
| L03.2 | Cellulitis and acute lymphangitis of face and neck |
| L03.21 | Cellulitis and acute lymphangitis of face |
| L03.211 | Cellulitis of face |
| L03.212 | Acute lymphangitis of face |
| L03.22 | Cellulitis and acute lymphangitis of neck |
| L03.221 | Cellulitis of neck |
| L03.222 | Acute lymphangitis of neck |
| L03.3 | Cellulitis and acute lymphangitis of trunk |
| L03.31 | Cellulitis of trunk |
| L03.311 | Cellulitis of abdominal wall |
| L03.312 | Cellulitis of back [any part except buttock and flank] |
| L03.313 | Cellulitis of chest wall |
| L03.314 | Cellulitis of groin |
| L03.315 | Cellulitis of perineum |
| L03.316 | Cellulitis of umbilicus |
| L03.317 | Cellulitis of buttock |
| L03.319 | Cellulitis of trunk, unspecified |
| L03.31A | Cellulitis of flank |
| L03.32 | Acute lymphangitis of trunk |
| L03.321 | Acute lymphangitis of abdominal wall |
| L03.322 | Acute lymphangitis of back [any part except buttock and flank] |
| L03.323 | Acute lymphangitis of chest wall |
| L03.324 | Acute lymphangitis of groin |
| L03.325 | Acute lymphangitis of perineum |
| L03.326 | Acute lymphangitis of umbilicus |
| L03.327 | Acute lymphangitis of buttock |
| L03.329 | Acute lymphangitis of trunk, unspecified |
| L03.32A | Acute lymphangitis of flank |
| L03.8 | Cellulitis and acute lymphangitis of other sites |
| L03.81 | Cellulitis of other sites |
| L03.811 | Cellulitis of head [any part, except face] |
| L03.818 | Cellulitis of other sites |
| L03.89 | Acute lymphangitis of other sites |
| L03.891 | Acute lymphangitis of head [any part, except face] |
| L03.898 | Acute lymphangitis of other sites |
| L03.9 | Cellulitis and acute lymphangitis, unspecified |
| L03.90 | Cellulitis, unspecified |
| L03.91 | Acute lymphangitis, unspecified |
| L05.0 | Pilonidal cyst and sinus with abscess |
| L05.01 | Pilonidal cyst with abscess |
| L05.02 | Pilonidal sinus with abscess |
| L08.0 | Pyoderma |
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| N48.21 | Abscess of corpus cavernosum and penis |
| N48.22 | Cellulitis of corpus cavernosum and penis |
| N75.1 | Abscess of bartholin's gland |
| N76.4 | Abscess of vulva |
| O91 | Infections of breast associated with pregnancy, the puerperium and lactation |
| O91.0 | Infection of nipple associated with pregnancy, the puerperium and lactation |
| O91.01 | Infection of nipple associated with pregnancy |
| O91.011 | Infection of nipple associated with pregnancy, first trimester |
| O91.012 | Infection of nipple associated with pregnancy, second trimester |
| O91.013 | Infection of nipple associated with pregnancy, third trimester |
| O91.019 | Infection of nipple associated with pregnancy, unspecified trimester |
| O91.02 | Infection of nipple associated with the puerperium |
| O91.03 | Infection of nipple associated with lactation |
| O91.1 | Abscess of breast associated with pregnancy, the puerperium and lactation |
| O91.11 | Abscess of breast associated with pregnancy |
| O91.111 | Abscess of breast associated with pregnancy, first trimester |
| O91.112 | Abscess of breast associated with pregnancy, second trimester |
| O91.113 | Abscess of breast associated with pregnancy, third trimester |
| O91.119 | Abscess of breast associated with pregnancy, unspecified trimester |
| O91.12 | Abscess of breast associated with the puerperium |
| O91.13 | Abscess of breast associated with lactation |
| Complicated skin structure s. pyogenes infection | |
| B95.0 | Streptococcus, group a, as the cause of diseases classified elsewhere |
| H00.03 | Abscess of eyelid |
| H00.031 | Abscess of right upper eyelid |
| H00.032 | Abscess of right lower eyelid |
| H00.033 | Abscess of eyelid right eye, unspecified eyelid |
| H00.034 | Abscess of left upper eyelid |
| H00.035 | Abscess of left lower eyelid |
| H00.036 | Abscess of eyelid left eye, unspecified eyelid |
| H00.039 | Abscess of eyelid unspecified eye, unspecified eyelid |
| H60.0 | Abscess of external ear |
| H60.00 | Abscess of external ear, unspecified ear |
| H60.01 | Abscess of right external ear |
| H60.02 | Abscess of left external ear |
| H60.03 | Abscess of external ear, bilateral |
| J34.0 | Abscess, furuncle and carbuncle of nose |
| K61 | Abscess of anal and rectal regions |
| K61.0 | Anal abscess |
| K61.1 | Rectal abscess |
| K61.2 | Anorectal abscess |
| K61.3 | Ischiorectal abscess |
| K61.4 | Intrasphincteric abscess |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L02.0 | Cutaneous abscess, furuncle and carbuncle of face |
| L02.01 | Cutaneous abscess of face |
| L02.03 | Carbuncle of face |
| L02.1 | Cutaneous abscess, furuncle and carbuncle of neck |
| L02.11 | Cutaneous abscess of neck |
| L02.13 | Carbuncle of neck |
| L02.2 | Cutaneous abscess, furuncle and carbuncle of trunk |
| L02.21 | Cutaneous abscess of trunk |
| L02.211 | Cutaneous abscess of abdominal wall |
| L02.212 | Cutaneous abscess of back [any part, except buttock and flank] |
| L02.213 | Cutaneous abscess of chest wall |
| L02.214 | Cutaneous abscess of groin |
| L02.215 | Cutaneous abscess of perineum |
| L02.216 | Cutaneous abscess of umbilicus |
| L02.217 | Cutaneous abscess of flank |
| L02.219 | Cutaneous abscess of trunk, unspecified |
| L02.23 | Carbuncle of trunk |
| L02.231 | Carbuncle of abdominal wall |
| L02.232 | Carbuncle of back [any part, except buttock and flank] |
| L02.233 | Carbuncle of chest wall |
| L02.234 | Carbuncle of groin |
| L02.235 | Carbuncle of perineum |
| L02.236 | Carbuncle of umbilicus |
| L02.237 | Carbuncle of flank |
| L02.239 | Carbuncle of trunk, unspecified |
| L02.3 | Cutaneous abscess, furuncle and carbuncle of buttock |
| L02.31 | Cutaneous abscess of buttock |
| L02.33 | Carbuncle of buttock |
| L02.4 | Cutaneous abscess, furuncle and carbuncle of limb |
| L02.41 | Cutaneous abscess of limb |
| L02.411 | Cutaneous abscess of right axilla |
| L02.412 | Cutaneous abscess of left axilla |
| L02.413 | Cutaneous abscess of right upper limb |
| L02.414 | Cutaneous abscess of left upper limb |
| L02.415 | Cutaneous abscess of right lower limb |
| L02.416 | Cutaneous abscess of left lower limb |
| L02.419 | Cutaneous abscess of limb, unspecified |
| L02.43 | Carbuncle of limb |
| L02.431 | Carbuncle of right axilla |
| L02.432 | Carbuncle of left axilla |
| L02.433 | Carbuncle of right upper limb |
| L02.434 | Carbuncle of left upper limb |
| L02.435 | Carbuncle of right lower limb |
| L02.436 | Carbuncle of left lower limb |
| L02.439 | Carbuncle of limb, unspecified |
| L02.5 | Cutaneous abscess, furuncle and carbuncle of hand |
| L02.51 | Cutaneous abscess of hand |
| L02.511 | Cutaneous abscess of right hand |
| L02.512 | Cutaneous abscess of left hand |
| L02.519 | Cutaneous abscess of unspecified hand |
| L02.53 | Carbuncle of hand |
| L02.531 | Carbuncle of right hand |
| L02.532 | Carbuncle of left hand |
| L02.539 | Carbuncle of unspecified hand |
| L02.6 | Cutaneous abscess, furuncle and carbuncle of foot |
| L02.61 | Cutaneous abscess of foot |
| L02.611 | Cutaneous abscess of right foot |
| L02.612 | Cutaneous abscess of left foot |
| L02.619 | Cutaneous abscess of unspecified foot |
| L02.63 | Carbuncle of foot |
| L02.631 | Carbuncle of right foot |
| L02.632 | Carbuncle of left foot |
| L02.639 | Carbuncle of unspecified foot |
| L02.8 | Cutaneous abscess, furuncle and carbuncle of other sites |
| L02.81 | Cutaneous abscess of other sites |
| L02.811 | Cutaneous abscess of head [any part, except face] |
| L02.818 | Cutaneous abscess of other sites |
| L02.83 | Carbuncle of other sites |
| L02.831 | Carbuncle of head [any part, except face] |
| L02.838 | Carbuncle of other sites |
| L02.9 | Cutaneous abscess, furuncle and carbuncle, unspecified |
| L02.91 | Cutaneous abscess, unspecified |
| L02.93 | Carbuncle, unspecified |
| L03 | Cellulitis and acute lymphangitis |
| L03.0 | Cellulitis and acute lymphangitis of finger and toe |
| L03.01 | Cellulitis of finger |
| L03.011 | Cellulitis of right finger |
| L03.012 | Cellulitis of left finger |
| L03.019 | Cellulitis of unspecified finger |
| L03.02 | Acute lymphangitis of finger |
| L03.021 | Acute lymphangitis of right finger |
| L03.022 | Acute lymphangitis of left finger |
| L03.029 | Acute lymphangitis of unspecified finger |
| L03.03 | Cellulitis of toe |
| L03.031 | Cellulitis of right toe |
| L03.032 | Cellulitis of left toe |
| L03.039 | Cellulitis of unspecified toe |
| L03.04 | Acute lymphangitis of toe |
| L03.041 | Acute lymphangitis of right toe |
| L03.042 | Acute lymphangitis of left toe |
| L03.049 | Acute lymphangitis of unspecified toe |
| L03.1 | Cellulitis and acute lymphangitis of other parts of limb |
| L03.11 | Cellulitis of other parts of limb |
| L03.111 | Cellulitis of right axilla |
| L03.112 | Cellulitis of left axilla |
| L03.113 | Cellulitis of right upper limb |
| L03.114 | Cellulitis of left upper limb |
| L03.115 | Cellulitis of right lower limb |
| L03.116 | Cellulitis of left lower limb |
| L03.119 | Cellulitis of unspecified part of limb |
| L03.12 | Acute lymphangitis of other parts of limb |
| L03.121 | Acute lymphangitis of right axilla |
| L03.122 | Acute lymphangitis of left axilla |
| L03.123 | Acute lymphangitis of right upper limb |
| L03.124 | Acute lymphangitis of left upper limb |
| L03.125 | Acute lymphangitis of right lower limb |
| L03.126 | Acute lymphangitis of left lower limb |
| L03.129 | Acute lymphangitis of unspecified part of limb |
| L03.2 | Cellulitis and acute lymphangitis of face and neck |
| L03.21 | Cellulitis and acute lymphangitis of face |
| L03.211 | Cellulitis of face |
| L03.212 | Acute lymphangitis of face |
| L03.22 | Cellulitis and acute lymphangitis of neck |
| L03.221 | Cellulitis of neck |
| L03.222 | Acute lymphangitis of neck |
| L03.3 | Cellulitis and acute lymphangitis of trunk |
| L03.31 | Cellulitis of trunk |
| L03.311 | Cellulitis of abdominal wall |
| L03.312 | Cellulitis of back [any part except buttock and flank] |
| L03.313 | Cellulitis of chest wall |
| L03.314 | Cellulitis of groin |
| L03.315 | Cellulitis of perineum |
| L03.316 | Cellulitis of umbilicus |
| L03.317 | Cellulitis of buttock |
| L03.319 | Cellulitis of trunk, unspecified |
| L03.31A | Cellulitis of flank |
| L03.32 | Acute lymphangitis of trunk |
| L03.321 | Acute lymphangitis of abdominal wall |
| L03.322 | Acute lymphangitis of back [any part except buttock and flank] |
| L03.323 | Acute lymphangitis of chest wall |
| L03.324 | Acute lymphangitis of groin |
| L03.325 | Acute lymphangitis of perineum |
| L03.326 | Acute lymphangitis of umbilicus |
| L03.327 | Acute lymphangitis of buttock |
| L03.329 | Acute lymphangitis of trunk, unspecified |
| L03.32A | Acute lymphangitis of flank |
| L03.8 | Cellulitis and acute lymphangitis of other sites |
| L03.81 | Cellulitis of other sites |
| L03.811 | Cellulitis of head [any part, except face] |
| L03.818 | Cellulitis of other sites |
| L03.89 | Acute lymphangitis of other sites |
| L03.891 | Acute lymphangitis of head [any part, except face] |
| L03.898 | Acute lymphangitis of other sites |
| L03.9 | Cellulitis and acute lymphangitis, unspecified |
| L03.90 | Cellulitis, unspecified |
| L03.91 | Acute lymphangitis, unspecified |
| L05.0 | Pilonidal cyst and sinus with abscess |
| L05.01 | Pilonidal cyst with abscess |
| L05.02 | Pilonidal sinus with abscess |
| L08.0 | Pyoderma |
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| L08.9 | Local infection of the skin and subcutaneous tissue, unspecified |
| M72.6 | Necrotizing fasciitis |
| N48.21 | Abscess of corpus cavernosum and penis |
| N48.22 | Cellulitis of corpus cavernosum and penis |
| N75.1 | Abscess of bartholin's gland |
| N76.4 | Abscess of vulva |
| O91 | Infections of breast associated with pregnancy, the puerperium and lactation |
| O91.0 | Infection of nipple associated with pregnancy, the puerperium and lactation |
| O91.01 | Infection of nipple associated with pregnancy |
| O91.011 | Infection of nipple associated with pregnancy, first trimester |
| O91.012 | Infection of nipple associated with pregnancy, second trimester |
| O91.013 | Infection of nipple associated with pregnancy, third trimester |
| O91.019 | Infection of nipple associated with pregnancy, unspecified trimester |
| O91.02 | Infection of nipple associated with the puerperium |
| O91.03 | Infection of nipple associated with lactation |
| O91.1 | Abscess of breast associated with pregnancy, the puerperium and lactation |
| O91.11 | Abscess of breast associated with pregnancy |
| O91.111 | Abscess of breast associated with pregnancy, first trimester |
| O91.112 | Abscess of breast associated with pregnancy, second trimester |
| O91.113 | Abscess of breast associated with pregnancy, third trimester |
| O91.119 | Abscess of breast associated with pregnancy, unspecified trimester |
| O91.12 | Abscess of breast associated with the puerperium |
| O91.13 | Abscess of breast associated with lactation |
| Complicated skin structure strep dysgalactiae infection | |
| B95.4 | Other streptococcus as the cause of diseases classified elsewhere |
| B95.5 | Unspecified streptococcus as the cause of diseases classified elsewhere |
| H00.03 | Abscess of eyelid |
| H00.031 | Abscess of right upper eyelid |
| H00.032 | Abscess of right lower eyelid |
| H00.033 | Abscess of eyelid right eye, unspecified eyelid |
| H00.034 | Abscess of left upper eyelid |
| H00.035 | Abscess of left lower eyelid |
| H00.036 | Abscess of eyelid left eye, unspecified eyelid |
| H00.039 | Abscess of eyelid unspecified eye, unspecified eyelid |
| H60.0 | Abscess of external ear |
| H60.00 | Abscess of external ear, unspecified ear |
| H60.01 | Abscess of right external ear |
| H60.02 | Abscess of left external ear |
| H60.03 | Abscess of external ear, bilateral |
| H60.1 | Cellulitis of external ear |
| H60.10 | Cellulitis of external ear, unspecified ear |
| H60.11 | Cellulitis of right external ear |
| H60.12 | Cellulitis of left external ear |
| H60.13 | Cellulitis of external ear, bilateral |
| J34.0 | Abscess, furuncle and carbuncle of nose |
| K61 | Abscess of anal and rectal regions |
| K61.0 | Anal abscess |
| K61.1 | Rectal abscess |
| K61.2 | Anorectal abscess |
| K61.3 | Ischiorectal abscess |
| K61.4 | Intrasphincteric abscess |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L02.0 | Cutaneous abscess, furuncle and carbuncle of face |
| L02.01 | Cutaneous abscess of face |
| L02.03 | Carbuncle of face |
| L02.1 | Cutaneous abscess, furuncle and carbuncle of neck |
| L02.11 | Cutaneous abscess of neck |
| L02.13 | Carbuncle of neck |
| L02.2 | Cutaneous abscess, furuncle and carbuncle of trunk |
| L02.21 | Cutaneous abscess of trunk |
| L02.211 | Cutaneous abscess of abdominal wall |
| L02.212 | Cutaneous abscess of back [any part, except buttock and flank] |
| L02.213 | Cutaneous abscess of chest wall |
| L02.214 | Cutaneous abscess of groin |
| L02.215 | Cutaneous abscess of perineum |
| L02.216 | Cutaneous abscess of umbilicus |
| L02.219 | Cutaneous abscess of trunk, unspecified |
| L02.23 | Carbuncle of trunk |
| L02.231 | Carbuncle of abdominal wall |
| L02.232 | Carbuncle of back [any part, except buttock and flank] |
| L02.233 | Carbuncle of chest wall |
| L02.234 | Carbuncle of groin |
| L02.235 | Carbuncle of perineum |
| L02.236 | Carbuncle of umbilicus |
| L02.239 | Carbuncle of trunk, unspecified |
| L02.3 | Cutaneous abscess, furuncle and carbuncle of buttock |
| L02.31 | Cutaneous abscess of buttock |
| L02.33 | Carbuncle of buttock |
| L02.4 | Cutaneous abscess, furuncle and carbuncle of limb |
| L02.41 | Cutaneous abscess of limb |
| L02.411 | Cutaneous abscess of right axilla |
| L02.412 | Cutaneous abscess of left axilla |
| L02.413 | Cutaneous abscess of right upper limb |
| L02.414 | Cutaneous abscess of left upper limb |
| L02.415 | Cutaneous abscess of right lower limb |
| L02.416 | Cutaneous abscess of left lower limb |
| L02.419 | Cutaneous abscess of limb, unspecified |
| L02.43 | Carbuncle of limb |
| L02.431 | Carbuncle of right axilla |
| L02.432 | Carbuncle of left axilla |
| L02.433 | Carbuncle of right upper limb |
| L02.434 | Carbuncle of left upper limb |
| L02.435 | Carbuncle of right lower limb |
| L02.436 | Carbuncle of left lower limb |
| L02.439 | Carbuncle of limb, unspecified |
| L02.5 | Cutaneous abscess, furuncle and carbuncle of hand |
| L02.51 | Cutaneous abscess of hand |
| L02.511 | Cutaneous abscess of right hand |
| L02.512 | Cutaneous abscess of left hand |
| L02.519 | Cutaneous abscess of unspecified hand |
| L02.53 | Carbuncle of hand |
| L02.531 | Carbuncle of right hand |
| L02.532 | Carbuncle of left hand |
| L02.539 | Carbuncle of unspecified hand |
| L02.6 | Cutaneous abscess, furuncle and carbuncle of foot |
| L02.61 | Cutaneous abscess of foot |
| L02.611 | Cutaneous abscess of right foot |
| L02.612 | Cutaneous abscess of left foot |
| L02.619 | Cutaneous abscess of unspecified foot |
| L02.63 | Carbuncle of foot |
| L02.631 | Carbuncle of right foot |
| L02.632 | Carbuncle of left foot |
| L02.639 | Carbuncle of unspecified foot |
| L02.8 | Cutaneous abscess, furuncle and carbuncle of other sites |
| L02.81 | Cutaneous abscess of other sites |
| L02.811 | Cutaneous abscess of head [any part, except face] |
| L02.818 | Cutaneous abscess of other sites |
| L02.83 | Carbuncle of other sites |
| L02.831 | Carbuncle of head [any part, except face] |
| L02.838 | Carbuncle of other sites |
| L02.9 | Cutaneous abscess, furuncle and carbuncle, unspecified |
| L02.91 | Cutaneous abscess, unspecified |
| L02.93 | Carbuncle, unspecified |
| L03 | Cellulitis and acute lymphangitis |
| L03.0 | Cellulitis and acute lymphangitis of finger and toe |
| L03.01 | Cellulitis of finger |
| L03.011 | Cellulitis of right finger |
| L03.012 | Cellulitis of left finger |
| L03.019 | Cellulitis of unspecified finger |
| L03.02 | Acute lymphangitis of finger |
| L03.021 | Acute lymphangitis of right finger |
| L03.022 | Acute lymphangitis of left finger |
| L03.029 | Acute lymphangitis of unspecified finger |
| L03.03 | Cellulitis of toe |
| L03.031 | Cellulitis of right toe |
| L03.032 | Cellulitis of left toe |
| L03.039 | Cellulitis of unspecified toe |
| L03.04 | Acute lymphangitis of toe |
| L03.041 | Acute lymphangitis of right toe |
| L03.042 | Acute lymphangitis of left toe |
| L03.049 | Acute lymphangitis of unspecified toe |
| L03.1 | Cellulitis and acute lymphangitis of other parts of limb |
| L03.11 | Cellulitis of other parts of limb |
| L03.111 | Cellulitis of right axilla |
| L03.112 | Cellulitis of left axilla |
| L03.113 | Cellulitis of right upper limb |
| L03.114 | Cellulitis of left upper limb |
| L03.115 | Cellulitis of right lower limb |
| L03.116 | Cellulitis of left lower limb |
| L03.119 | Cellulitis of unspecified part of limb |
| L03.12 | Acute lymphangitis of other parts of limb |
| L03.121 | Acute lymphangitis of right axilla |
| L03.122 | Acute lymphangitis of left axilla |
| L03.123 | Acute lymphangitis of right upper limb |
| L03.124 | Acute lymphangitis of left upper limb |
| L03.125 | Acute lymphangitis of right lower limb |
| L03.126 | Acute lymphangitis of left lower limb |
| L03.129 | Acute lymphangitis of unspecified part of limb |
| L03.2 | Cellulitis and acute lymphangitis of face and neck |
| L03.21 | Cellulitis and acute lymphangitis of face |
| L03.211 | Cellulitis of face |
| L03.212 | Acute lymphangitis of face |
| L03.22 | Cellulitis and acute lymphangitis of neck |
| L03.221 | Cellulitis of neck |
| L03.222 | Acute lymphangitis of neck |
| L03.3 | Cellulitis and acute lymphangitis of trunk |
| L03.31 | Cellulitis of trunk |
| L03.311 | Cellulitis of abdominal wall |
| L03.312 | Cellulitis of back [any part except buttock and flank] |
| L03.313 | Cellulitis of chest wall |
| L03.314 | Cellulitis of groin |
| L03.315 | Cellulitis of perineum |
| L03.316 | Cellulitis of umbilicus |
| L03.317 | Cellulitis of buttock |
| L03.319 | Cellulitis of trunk, unspecified |
| L03.32 | Acute lymphangitis of trunk |
| L03.321 | Acute lymphangitis of abdominal wall |
| L03.322 | Acute lymphangitis of back [any part except buttock and flank] |
| L03.323 | Acute lymphangitis of chest wall |
| L03.324 | Acute lymphangitis of groin |
| L03.325 | Acute lymphangitis of perineum |
| L03.326 | Acute lymphangitis of umbilicus |
| L03.327 | Acute lymphangitis of buttock |
| L03.329 | Acute lymphangitis of trunk, unspecified |
| L03.8 | Cellulitis and acute lymphangitis of other sites |
| L03.81 | Cellulitis of other sites |
| L03.811 | Cellulitis of head [any part, except face] |
| L03.818 | Cellulitis of other sites |
| L03.89 | Acute lymphangitis of other sites |
| L03.891 | Acute lymphangitis of head [any part, except face] |
| L03.898 | Acute lymphangitis of other sites |
| L03.9 | Cellulitis and acute lymphangitis, unspecified |
| L03.90 | Cellulitis, unspecified |
| L03.91 | Acute lymphangitis, unspecified |
| L05.0 | Pilonidal cyst and sinus with abscess |
| L05.01 | Pilonidal cyst with abscess |
| L05.02 | Pilonidal sinus with abscess |
| L08.0 | Pyoderma |
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| L08.9 | Local infection of the skin and subcutaneous tissue, unspecified |
| M72.6 | Necrotizing fasciitis |
| N48.21 | Abscess of corpus cavernosum and penis |
| N48.22 | Cellulitis of corpus cavernosum and penis |
| N75.1 | Abscess of bartholin's gland |
| N76.4 | Abscess of vulva |
| N76.82 | Fournier disease of vagina and vulva |
| O91 | Infections of breast associated with pregnancy, the puerperium and lactation |
| O91.0 | Infection of nipple associated with pregnancy, the puerperium and lactation |
| O91.01 | Infection of nipple associated with pregnancy |
| O91.011 | Infection of nipple associated with pregnancy, first trimester |
| O91.012 | Infection of nipple associated with pregnancy, second trimester |
| O91.013 | Infection of nipple associated with pregnancy, third trimester |
| O91.019 | Infection of nipple associated with pregnancy, unspecified trimester |
| O91.02 | Infection of nipple associated with the puerperium |
| O91.03 | Infection of nipple associated with lactation |
| O91.1 | Abscess of breast associated with pregnancy, the puerperium and lactation |
| O91.11 | Abscess of breast associated with pregnancy |
| O91.111 | Abscess of breast associated with pregnancy, first trimester |
| O91.112 | Abscess of breast associated with pregnancy, second trimester |
| O91.113 | Abscess of breast associated with pregnancy, third trimester |
| O91.119 | Abscess of breast associated with pregnancy, unspecified trimester |
| O91.12 | Abscess of breast associated with the puerperium |
| O91.13 | Abscess of breast associated with lactation |
| Right-sided s. aureus endocarditis | |
| B95.6 | Staphylococcus aureus as the cause of diseases classified elsewhere |
| B95.61 | Methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere |
| B95.62 | Methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere |
| I33.0 | Acute and subacute infective endocarditis |
| I33.9 | Acute and subacute endocarditis, unspecified |
| Staphylococcus aureus septicemia | |
| A41.0 | Sepsis due to staphylococcus aureus |
| A41.01 | Sepsis due to methicillin susceptible staphylococcus aureus |
| A41.02 | Sepsis due to methicillin resistant staphylococcus aureus |
| P36.2 | Sepsis of newborn due to staphylococcus aureus |
Formulary Reference Tool